Real-world management of oral factor Xa inhibitor-related bleeds with reversal or replacement agents including andexanet alfa and four-factor prothrombin complex concentrate: a multicenter study

Future Cardiology, Ahead of Print.

Source: Future Cardiology - July 2, 2020 Category: Cardiology Authors: Craig I Coleman Paul P Dobesh Sherry Danese Julie Ulloa Belinda Lovelace Source Type: research